← Eichor
Condition: Invasive Ductal Carcinoma Of Female Breast Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Invasive Ductal Carcinoma Of Female Breast

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
Phase N/A · 2 location(s) · RPCR, Inc. · NCT04985032
Radiation After No Axillary Nodal Sampling
NA · 1 location(s) · NYU Langone Health · NCT07723209
[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 2 · 6 location(s) · Blue Earth Diagnostics · NCT07702292
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3 · 1 location(s) · RenJi Hospital · NCT03201861
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Phase 2 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT04084730
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · ITM Oncologics GmbH · NCT05706129
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 1/Phase 2 · 1 location(s) · Blue Earth Diagnostics · NCT07432633
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.